How do I buy Nurix Therapeutics (NRIX) stock?

You can purchase shares of Nurix Therapeutics (NASDAQ:NRIX) through any online brokerage.View our list of the best stock brokerages

Who are Nurix Therapeutics (NRIX) competitors?

Other companies in Nurix Therapeutics’s space includes: Immunome Inc (NASDAQ:IMNM), Ultragenyx Pharmaceutical Inc (NASDAQ:RARE), Sarepta Therapeutics Inc (NASDAQ:SRPT), Upstream Bio Inc (NASDAQ:UPB) and Ascentage Pharma Group International (NASDAQ:AAPG).

What is the forecast, or price target, for Nurix Therapeutics (NRIX) stock?

Nurix Therapeutics has a consensus price target of $30.24.

What is the current price for Nurix Therapeutics (NRIX)?

The stock price for Nurix Therapeutics (NASDAQ: NRIX) is $19.21 last updated January 16, 2026 at 4:02 PM EST.

Does Nurix Therapeutics (NRIX) pay a dividend?

There are no upcoming dividends for Nurix Therapeutics.

When is Nurix Therapeutics (NASDAQ:NRIX) reporting earnings?

Nurix Therapeutics does not have any upcoming earnings scheduled.

Is Nurix Therapeutics (NRIX) going to split?

There is no upcoming split for Nurix Therapeutics.

What sector and industry does Nurix Therapeutics (NRIX) operate in?

Nurix Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Nurix Therapeutics (NRIX) Stock Price, Quote, News & History

Bulls vs Bears

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Name

Revenue

Change

Gross

Change

EBITDA

Change

EBIT

Change

Earnings

Change

About

Sector

Health Care

Industry

Biotechnology

Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disor...

Comments